Dmk Pharmaceuticals Corp

DMKCIK 0000887247 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 1, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0030

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Jul 1, 2024no items parsed Feb 7, 2024no items parsed Feb 5, 2024no items parsed Jan 31, 2024no items parsed Jan 23, 2024no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Dmk Pharmaceuticals Corp

Name	Roles	Filings
Dorbin John W. Jr.	Officer	1
Marguglio David J.	OfficerDirector	1
Moss Ronald B.	Officer	1
Reed Vickie S	Director	1
Versi Jannine	Director	1

Showing 6-10 of 10

Per pagePrevPage 2 of 2

All filings

12 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Nov 2, 2023	Dorbin John W. Jr. General Counsel	Holdings only	-	-	-
Oct 25, 2023	Cohen Seth CFO	Holdings only	-	-	-
Sep 19, 2023	Versi Ebrahim CEO · Director	CConversion	729,200	$0.00	$0
May 30, 2023	Versi Jannine Director	AGrant	177,194	-	-
May 30, 2023	Desai Meera J. Director	AGrant	3,138	-	-

Showing 1-5 of 12

Per pagePage 1 of 3Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value